Drugs / CD8 enriched Young TIL
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01118091 | Apr 2010 → Apr 2012 | metastatic melanoma, skin cancer | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD8 enriched Young TIL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01118091 ↗ |
| Modality | Cell therapy | “Adoptive Cell Therapy” NCT01118091 ↗ |